|
Real-time Estimate
Cboe BZX
10:52:14 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 17.06 USD | -0.09% |
|
-8.30% | -1.54% |
| 10-16 | Omeros Shares Fall After Narsoplimab Application Rejected Again by EU Agency | MT |
| 10-16 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Amid Investor Caution | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OMEROS CORPORATION | Bio Therapeutic Drugs | -1.29% | -8.30% | -1.54% | +156.99% | +126.68% | 1.24B |  |  | |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
